Diabetic kidney disease
Conditions
Interventions
Group A:In the first stage, individules was treated with Xiaozheng Qufeng granule for 4 weeks, and then stop intervention, entering a 4-week cleansing period. After cleaning period, individules was tr
Group B:In the first stage, individules was treated with placebo for 4 weeks, and then stop intervention, entering a 4-week cleansing period. After cleaning period, individules was treated with Xiaozh
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: ?Female or male, aged 18-70 years old. ?Meet the diagnostic and staging criteria for G2-3aA2 DKD and the diagnostic criteria for Qi deficiency and blood stasis syndrome. ?Those with stable blood pressure below 140/90mmHg and glycated hemoglobin controlled below 7.5%. ?Those who voluntarily participate in this clinical trial and have signed the informed consent form.
Exclusion criteria
Exclusion criteria: ?Individuals with a history of critical illnesses such as malignant hypertension, myocardial infarction, cerebrovascular accidents, and diabetic ketoacidosis within the past six months. ?Patients with congestive heart failure of Class I-IV. ?Accompanied by other primary and secondary kidney diseases (chronic nephritis, kidney disease caused by hypertension, gout, lupus erythematosus, etc.) ?Not suitable for receiving this treatment plan due to conditions such as cancer, pregnancy, and allergy. ?Those who have participated in other clinical trials in the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary albumin-to-creatinine ratio; | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine Syndrome Score; | — |
Countries
China
Contacts
Public ContactQiang Fu
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Outcome results
None listed